• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login
Forgot Password?
Sign Up
loader image
New User? Sign Up
Forgot Password?
Login
loader image

    Breast Cancer: Updates in the Use of CDK4/6 Inhibition for Breast Cancer

    Moderated by Dr. Kelly McCann

    During this conversation on hormone-receptor positive, HER2-negative breast cancer, we will discuss two cases and share perspectives on how new data are shaping our use of CDK4/6 inhibitors.

    Interested in joining the Targeted Oncology™ Case-Based Roundtable® ?  In-person seating is limited to 14 participants.

    To be eligible to attend this meeting, physicians must be practicing medical oncologists or hematologists treating patients for the specified tumor type and located within the event region.

    Please note that fellows are not eligible to attend this meeting unless otherwise specified.

    This discussion is IN-PERSON only, there are no virtual options.

    CASE-BASED ROUNDTABLE DETAILS

    DATE & TIME

    Thursday, November 20, 2025
    7:00 PM - 9:00 PM PT
     

    EVENT VENUE

    Fleming's Prime Steakhouse & Wine Bar

    800 West Olympic Blvd., Los Angeles, CA 90015


    Moderator

    Join Targeted Oncology for a collaborative, small-group meeting designed around case-based clinical profiles and peer-dialogue led by an expert physician.  This session offers practicing oncologists the perfect opportunity to sharpen their skills and expertise in treatment strategies.



    image placeholder
    KM
    Kelly McCann, MD, PhD
    Medical Oncologist
    UCLA

    VENUE LOCATION

    Fleming's Prime Steakhouse & Wine Bar800 W Olympic Blvd, Los Angeles, CA 90015, USA

    The Value of Targeted Oncology Discussions

    "Targeted Oncology provides educational materials that I can bring to my practice that can influence the way I practice each day. It’s a great opportunity to find out what peers are doing and see what the latest data shows as well." - Jason Levitz, MD

    "Attending these discussions is a great way to get a sense of the latest and greatest. Right now in oncology, it’s hard to keep up with everything—there’s constantly new data coming out of conferences. Having someone put that into context - while you’re also able to discuss cases with community members and fellow physicians, is a great way to stay up to date to and educated." - Andrew Lipsky, MD

    "Targeted Oncology discussions have influenced my clinical practice by helping me learn what other community oncologists are doing. I think it’s great to attend these forums where collectively we can learn from each other how to continue treating our patients the best way possible." - Eshan Patel, MD, MBA

    MARKET RESEARCH PARTICIPATION

    This event is held in partnership with Healthcare Research & Analytics to gain market research insights into health care professional’s educational needs in their current practice setting.   


    HRA® offers compensation of $650 to oncologists for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.



    Targeted Healthcare Communications® — an MJH Life Sciences® Brand

    259 Prospect Plains Rd., Building H, Monroe, NJ 08831

    Copyright 2025 © Intellisphere, LLC.  All Rights Reserved.

    Terms & Conditions

    Privacy Policy

     

    Do Not Sell My Info
Looking for your ticket? Contact the organizer
Looking for your ticket? Contact the organizer